Skip to main content

Iron status and its relation to lung function in pediatric asthmatics: a cross-sectional study

Abstract

Background

Asthma and iron deficiency are common pediatric conditions. In addition, iron deficiency may affect spirometry results in asthmatic children. So, we aimed to assess the effect of ion status on lung function in childhood asthma.

Results

In this cross-sectional study, fifty asthmatic pediatric patients aged from 6 to 16 years presented to our institute during the period from (June 2018 to December 2018) were enrolled. Asthmatic patients were classified according to their complete blood count and iron profile into 2 groups: group 1, asthmatic children without iron deficiency anemia (IDA); and group 2, asthmatic children with IDA. All patients underwent full history taking, clinical examination, laboratory investigations, asthma control test, and pulmonary function tests (PFTs). The study showed that PFTs’ parameters (forced expiratory volume in one second (FEV1) % of predicted, FEV1/forced vital capacity, and maximal mid expiratory flow (MMEF) 25–75% of predicted) were significantly lower among asthmatics with IDA (80.62 ± 18.13, 78.36 ± 11.22, 62.35 ± 26.67) than among asthmatics without IDA (93.45 ± 15.51, 87.68 ± 10.81, 82.10 ± 24.74), respectively (p =0.012, 0.006, 0.012). Also, poorly controlled asthma was significantly higher among asthmatics with IDA (p =0.001). In addition, there was a statistically significant positive correlation between forced spirometry parameters, hemoglobin, and ferritin level (p=0.012, 0.042). Moreover, there was a significant positive correlation between hemoglobin level and MMEF 25–75% of predicted (p=0.012).

Conclusions

Lower iron status negatively affects the lung function in asthmatic children with a more obstructive pattern among asthmatics with IDA.

Background

Asthma is a wide public health problem affecting 8.4% of children [1]. Its incidence increased worldwide [2]. Pathophysiologic occasions creating asthma, including inflammation, upsurges in Th2 cells, and muscle tightening, can associate with iron obtainability [3, 4].

Preservation of iron homeostasis is of extreme importance for the respiratory physiology and pathophysiology where local iron deficit may result in certain respiratory function impairment of forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC, and peak expiratory flow [5]. Therefore, the objective of the current study was to evaluate the impact of iron status on the results of pulmonary function tests among asthmatic children.

Materials and methods

Study design and setting

This cross-sectional study was carried out on fifty asthmatic children in the age group of 6–16 years who were attending our institute during the period from (June 2018 to December 2018). The study was registered at https://www.clinicaltrials.gov/ (ID: NCT05277610).

The study was approved by the Ethics Research Committee of the Faculty of Medicine, Ain Shams University. All patients were invited to participate, and informed consents were obtained from their parents or guardians and children older than 7 years prior to inclusion in the study.

Study subjects

Inclusion criteria

  1. A.

    Confirmed diagnosis of bronchial asthma: The diagnosis of bronchial asthma in the studied children was based on clinical examination and applying the following criteria mentioned in previous studies [6, 7]:

    1. 1.

      History of recurrent or chronic symptoms characteristic of asthma (more than three episodes were present).

    2. 2.

      The findings on physical check of distinctive musical wheezing (present in relationship with signs and absent with signs’ resolution).

    3. 3.

      The demonstration of variable expiratory airflow limitation by spirometry (a post-bronchodilator increase in FEV1 of >12%) [8].

    4. 4.

      Exclusion of alternative diagnoses

  2. B.

    The diagnosis of iron deficiency anemia was supported by criteria provided and updated by World Health Organization [9, 10].

Exclusion criteria

A) Chronic lung diseases other than asthma; (B) any known hematological disorders like thalassemia or any other type of anemia other than IDA; (C) severe systemic illness as liver, renal diseases, and nutritional disorders; (D) congenital malformations of the chest wall; (E) wheezes for the first time, and (F) if the patients were taking any iron supplementation at the time of the study or in the previous 3 months prior to the study.

Study methods

For each child, a detailed medical history was obtained including the personal history, history of present illness including intermittent or recurrent symptoms of cough, shortness of breath, wheezes, dyspnea, chest tightness and pallor, history of allergy and exposure to precipitating factors, nutritional history, history of passive smoking, and family history of atopy.

In addition, all children included in the study were subjected to a thorough clinical examination with a special stress on chest examination including signs of tachypnea, hyperinflated chest, hype-resonance on percussion, signs of respiratory distress, prolonged expiratory period, and expiratory rhonchi on chest auscultation, along with the anthropometric measurements including body mass index (BMI) which was calculated using the following formula: BMI=weight/height2 in meter square. Chest X-ray was done to exclude other causes of wheezes rather than asthma. Furthermore, complete blood count (CBC), iron profile (Serum iron, serum total iron binding capacity (TIBC), serum ferritin, and transferrin saturation) were reviewed from the patients’ records in the previous month. Asthma control level was measured for all the studied patients by the Global Initiative for Asthma (GINA) criteria [11], and the Asthma Control Test (ACT) [12], ACT consists of five items. It has been applied for asthmatic patients from the age of 12 years evaluating the preceding 4 weeks and a seven-item childhood ACT (C-ACT) which has been used in asthmatic children aged 4–11 years [13]. A score cut-off point of 19 indicated uncontrolled asthma for both questionnaires. Additionally, pulmonary function tests (PFTs) were performed for cooperative children older than 6 years with average mentality.

Study procedure

Pulmonary function testing was performed using standardized spirometry. It was done for asthmatic patients using (JAEGER apparatus, Care Fusion Germany, 2011). Lung function was measured by forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC, and maximal mid-expiratory flow (MMEF 25–75%) of FVC. Each was measured 3 times, and the best effort was recorded. All of FEV1, FVC, and MMEF 75/25 measurements are reported as percent of predicted values for age, height, and sex. All pulmonary function tests were performed and interpreted according to the American Thoracic Society Guidelines (ATS)/European Respiratory Society (ERS) standards [14, 15].

Statistical analysis

The results were statistically analyzed using the statistical package for social sciences, version 20.0 using (SPSS Inc., Chicago, Illinois, USA [16]. Numerical variables were reported in terms of mean and standard deviations (SD). Categorized variables were reported in terms of numbers (n) and percentages (%). The baseline characteristics of asthmatic children with or without anemia were compared using unpaired “Student’s” t test and chi-square tests for parametric and non-parametric parameters. Correlations between various variables were done using Pearson correlation equation for linear relation in normally distributed variables. The P value less than 0.05 was considered to be statistically significant.

Sample size calculation

The sample size was calculated using PASS 11.0 and was based on a study carried out by AlKhateeb et al. [17]. Group sample sizes of at least 17 patients in group 1 (asthmatic patients without iron deficiency anemia) and 17 patients in group 2 (asthmatic patients with iron deficiency anemia) achieve 81% power to detect a difference of −9.1 between the null hypothesis that both group means are 52.3 and the alternative hypothesis that the mean of group 1 is 61.4 with the estimated group standard deviations of 10.0 and 8.0 and with a significance level (alpha) of 0.05000 using a two-sided two-sample t test. The primary outcome variable is FEV1/FVC. The sample size calculation was based on comparisons between two means.

Results

The study included fifty children diagnosed as bronchial asthma. According to their hemoglobin levels and iron profile, asthmatic patients were divided into two groups: group 1, asthmatic children without IDA (66%) (n=33); and group 2, asthmatic children with IDA (34%) (n=17).

No statistically significant differences regarding the demographic and anthropometric data were observed between asthmatic patients with and without IDA (p>0.05) (data not shown).

Pulmonary function test parameters among the studied patients

As shown in Table 1, there was a statistically significant difference between group 1 and group 2 concerning respiratory function limitations in (FEV1% of predicted, FEV1/FVC, MMEF 25–75% of predicted) which were superior in group 2 (asthmatics with IDA) (52.9%), (58.8%), and (53%), than in group 1 (asthmatics without IDA) (18.2%), (15.2%), and (12.1%), respectively, which denoted that anemic asthmatics had more pronounced deterioration of lung function on spirometry study than those with asthma alone (p value =0.011, 0.019, and 0.018), respectively.

Table 1 Comparison between groups 1 and 2 regarding pulmonary function test parameters

The pulmonary function tests’ results in relation to IDA

There was a statistically significant difference between group 1 and group 2 regarding the pulmonary function test results where moderate to moderately severe obstructive pattern was significantly higher in group 2 (35.2%) than group 1 (9.1%), denoting a more severe airway disease among asthmatics with IDA (p = 0.032), as shown in Table 2.

Table 2 Comparison between asthmatics without IDA and asthmatics with IDA according to the pulmonary function test results

Asthma control level and iron status

As displayed in Table 3, there mean C-ACT score was significantly lower among asthmatics with IDA (15.29 ± 2.46) than those without IDA (20.04 ± 2.32), (p value < 0.001). In addition, very poorly controlled asthma was significantly more prevalent among the patients of group 2 (47.1%) compared to those of group 1 (6.1%) (p value=0.001), indicating that asthmatics with IDA suffered from a more severe disease.

Table 3 Comparison between asthmatics without IDA and asthmatics with IDA according to the asthma control test

Lung function relations with CBC parameters, hemoglobin level, and iron profile

There was a statistically significant association between PFTs’ results and hemoglobin level, in which a lower hemoglobin level was associated with worse PFT results, denoting a higher asthma severity (p value=0.03), as presented in Table 4.

Table 4 Relations between pulmonary function test results and CBC parameters in the studied patients

In addition, there were statistically significant negative correlations between severity of asthma measured by reduced FEV1/FVC ratio with hemoglobin and ferritin levels in which lower hemoglobin and ferritin levels were associated with lower FEV1/FVC, and higher asthma severity, and vice versa as shown in Table 5 (p value=0.012 and 0.042).

Table 5 Correlations between severity of asthma with haemoglobin level, iron profile, using Pearson correlation coefficient in asthmatic patients (with and without IDA)

Finally, as shown in Table 6 and Fig. 1, there was a statistically significant positive correlation between MMEF 25 and 75% of predicted with hemoglobin level in which a lower hemoglobin level was associated with a lower MMEF 25–75% results and vice versa denoting a more severe small air way disease in anaemic asthmatics than those with asthma alone (p value=0.012).

Table 6 Correlations between pulmonary function test parameters with haemoglobin level, iron profile, using Pearson correlation coefficient in asthmatic patients (with and without IDA)
Fig. 1
figure 1

A positive correlation between MMEF 25–75% and hemoglobin level

Discussion

Asthma is a substantial public health problem worldwide. It is one of the most common chronic diseases in pediatric population [18]. Iron-deficiency anemia (IDA) is frequently seen in pediatric practice [19]. It has already been reported that low hemoglobin level impairs tissue oxygenation [20] and may adversely affect respiratory functions in normal subjects [21, 22].

The current study revealed strong associations between lower iron status and reduced lung function among asthmatic children and therefore higher asthma severity.

To the best of our knowledge, the present study is one of the fewest studies that investigated the influence of low iron status on the lung function in childhood asthma in order to define one of asthma modifiable risk factors hoping to reduce asthma morbidity and severity.

Our analysis found that asthmatics with IDA were more likely to have lower lung function parameters compared to those without IDA (p value =0.012, 0.006, and 0.012) (Tables 1 and 4), which coincided with Eissa et al. [8] who reported in a study conducted on 100 children with upper or lower respiratory tract infection which revealed that pulmonary function parameters were significantly higher among non-anemic asthmatics than among anemic asthmatics.

A similar observation was reported by Alkhateeb et al. [17] in a study conducted on 100 patients with IDA and 100 children without IDA which stated that those with asthma with anemia had more pronounced deterioration of pulmonary function on spirometry study than those with asthma alone (p value<0.05).

Moreover, several previous studies reported that higher iron stores were inversely associated with asthma and lower body iron and higher tissue iron need were associated with lower lung function [23, 24].

Our findings can be explained by the negative effect of anemia on the strength of respiratory muscles which reduces the lung function [25, 26]. In addition, iron deficiency impairs the immune system function [26] which increases the risk of respiratory tract infections, thus aggravating the frequency and severity of asthma attacks in asthmatic children which reduces lung function.

The present study showed that a moderate to severe obstructive pattern was significantly observed among asthmatics with IDA than those without (p = 0.032) (Table 2). In addition, anemic asthmatic children were more likely to have very poor asthma control than those with asthma alone (p=0.001) (Table 3).

In addition, C-ACT score had a statistically significant negative correlation (r =−0.399, p= 0.012) with TIBC and a positive one with transferrin saturation (r=0.418, p= 0.008) indicating poor asthma control among asthmatics with IDA (data not shown in the results).

These findings are in line with several previously published studies [24, 27, 28], which reported that greater iron stores were inversely associated with asthma and lesser body iron levels were associated with frequent asthma symptoms, poor asthma control, and lower lung function.

Moreover, our study revealed that asthmatic patients with lower lung function tend to have lower haemoglobin and ferritin levels (p value= 0.012 and 0.042) (Table 5). Besides, there was a strong correlation between MMEF 25 and 75% of predicted, and hemoglobin level (p value=0.012) (Table 6, Fig. 1), denoting a more severe small air way disease among anaemic asthmatics than those asthmatics without anemia.

Our findings go parallel with recent studies conducted by Eissa et al. [8] and Alkhateeb et al. [17] who reported a significant direct relation between serum ferritin value and lung function parameters.

Our results are also in conform with Fida and colleagues [28] who found positive correlation between higher hemoglobin and better lung function results in asthmatic children, and also, they added that higher tissue iron needs were correlated with lower lung function.

Furthermore, it was noted by Nwaru et al. [29] and Lanzkowsky et al. [30] that maternal serum ferritin in the 1st trimester was positively correlated with pulmonary function and development of wheezing at 10 years of age.

In contrast to these findings, Brigham et al. [21] reported in a study conducted on 1046 adolescent females in the age group from 12 to 19 years, that no significant relationships were observed between any of the iron indices and lung function, which may be due to low prevalence of IDA among the studied population.

These aforementioned findings of our study declared the substantial effect of iron deficiency on lung function reduction and poor asthma control and therefore aggravating asthma severity.

Study limitations

The current study has some limitations. First, the sample size was relatively small. Second, the design was cross-sectional and further longitudinal studies are needed to confirm our findings. Finally, this work was a single-center experience; therefore, larger multicentric studies are needed to generalize our results.

Conclusion

IDA is not uncommon in asthmatic children and lower iron status was associated with lower lung function. Therefore, regular screening and early treatment of IDA in asthmatics may be simple, cheap, and cost-effective tool for improving asthma control, enhancing lung function, and reducing asthma severity in low-income societies.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Abbreviations

FEV1:

Forced expiratory volume in one second

FVC:

Forced vital capacity

CBC:

Complete blood count

TIBC:

Total iron binding capacity

GINA:

Global Initiative for Asthma

ACT:

Asthma control test

IDA:

Iron deficiency anemia

PFTs:

Pulmonary function tests

MMEF 25–75%:

Maximal mid-expiratory flow

ATS:

American Thoracic Society Guidelines

ERS:

European Respiratory Society

References

  1. Zahran HS, Vorce T (2018) Asthma in children: working together to get it under control

    Google Scholar 

  2. Kumar L (1999) Consensus guidelines on management of childhood asthma in India. Indian Pediatr 36(2):157–165

    CAS  PubMed  Google Scholar 

  3. Boulet L-P, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O’Byrne PM (2019) The global initiative for asthma (GINA): 25 years later. Eur Respir J 54(2):1900598. https://doi.org/10.1183/13993003.00598-2019

  4. Tan LD, Alismail A, Ariue B (2022) Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021. Curr Opin Pulm Med 28(3):234–244

    Article  Google Scholar 

  5. Ghio AJ (2016) Asthma as a disruption in iron homeostasis. Biometals 29(5):751–779

    Article  CAS  Google Scholar 

  6. National Asthma Education, Prevention Program (National Heart, Lung, Blood Institute). Second Expert Panel on the Management of Asthma, National Heart, Lung, & Blood Institute. National Asthma Education Program. Expert Panel on the Management of Asthma. (1998). Expert panel report 2: guidelines for the diagnosis and management of asthma. National Institutes of Health, National Heart, Lung, and Blood Institute

  7. Network BTSSIG (2008) British guideline on the management of asthma. Thorax 63:iv1–iv121

    Article  Google Scholar 

  8. Eissa SA, Mohammad AA-E, Ibrahim SA-E, Abd-Elgwad ER, Soliman NSAE (2016) Iron deficiency anemia as a risk factor in childhood asthma. Egypt J Chest Dis Tuberc 65(4):733–737. https://doi.org/10.1016/j.ejcdt.2016.05.004

    Article  Google Scholar 

  9. Organization, W. H (2017) Hemoglobin concentrations for the diagnosis of anemia and assessment of severity. Vitamin and Mineral Nutrition Information System. World Health Organization (WHO/NMH/NHD/MNM/11.1), Geneva

    Google Scholar 

  10. Who, Unicef (2001) "Unu." Iron deficiency anaemia: assessment, prevention and control, a guide for programme managers. Geneva: World Health Organization 1–114

  11. Becker AB, Abrams EM (2017) Asthma guidelines: the Global Initiative for Asthma in relation to national guidelines. Curr Opin Allergy Clin Immunol 17(2):99–103

    Article  Google Scholar 

  12. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P et al (2004) Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113(1):59–65

    Article  Google Scholar 

  13. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S et al (2007) Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 119(4):817–825

    Article  Google Scholar 

  14. Society, A. T (1995) Standardization of spirometry. Am J Respir Crit Care Med 152:1107–1136

    Article  Google Scholar 

  15. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A (2005) Standardisation of spirometry. Eur Respir J 26:319–338 Find this article online

    Article  CAS  Google Scholar 

  16. Levesque R (2005). SPSS programming and data management: a guide for SPSS and SAS Users

  17. Alkhateeb MS, Khalil HM, Kadhim MM, Alezzi JI (2019) Iron deficit anemia as a risk factor of asthma. Diyala J Med 17(2):174–181. https://doi.org/10.26505/djm.17024860807

    Article  Google Scholar 

  18. Bener A, Ehlayel MS, Hamid Q (2015) The impact of anemia and hemoglobin level as a risk factor for asthma and allergic diseases. Indian J Allergy Asthma Immunol 29(2):72

    Article  Google Scholar 

  19. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L (2016) Iron deficiency anaemia. Lancet 387(10021):907–916

    Article  CAS  Google Scholar 

  20. Nairz M, Haschka D, Demetz E, Weiss G (2014) Iron at the interface of immunity and infection. Front Pharmacol 5:152

    Article  Google Scholar 

  21. Brigham EP, McCormack MC, Takemoto CM, Matsui EC (2015) Iron status is associated with Asthma and lung function in US women. PLoS One 10(2):1–12. https://doi.org/10.1371/journal.pone.0117545

    Article  CAS  Google Scholar 

  22. Guyton AC, Hall JA (2006) Effect of hemoglobin to buffer the tissue PO2. In: Text Book of Medical Physiology. 11th ed. Saunders, Philadelphia, pp 507–508

    Google Scholar 

  23. Baker RD, Greer FR, Nutrition C, on. (2010) Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics 126(5):1040–1050

    Article  Google Scholar 

  24. Hale LP, Kant EP, Greer PK, Foster WM (2012) Iron supplementation decreases severity of allergic inflammation in murine lung

    Book  Google Scholar 

  25. Xu S, Xue Y (2016) Pediatric obesity: causes, symptoms, prevention and treatment. Exp Ther Med 11(1):15–20

    Article  Google Scholar 

  26. Thibault H, Galan P, Selz F, Preziosi P, Olivier C, Badoual J, Hercberg S (1993) The immune response in iron-deficient young children: effect of iron supplementation on cell-mediated immunity. Eur J Pediatr 152(2):120–124

    Article  CAS  Google Scholar 

  27. Abdelaziz AO, Abd El-Ghany EHAEH, Makram O, Abd El-Aziz MO, El-Hoseany Magdy M, El-Sharkawy E (2018) Prevalence and impact of anemia in patients with chronic respiratory diseases. Egypt J Chest Dis Tuberc 67(4):461–470. https://doi.org/10.4103/ejcdt.ejcdt

    Article  Google Scholar 

  28. Fida NM, Kamfar HZ (2013) Is iron deficiency anemia a risk factor in asthmatic children. Department of Pediatrics, Faculty of Medicine King Abdul-Aziz University, Jeddah, Saudi Arabia JKAU. Med Sci 20(1):3–14

    Google Scholar 

  29. Nwaru BI, Hayes H, Gambling L, Craig LCA, Allan K, Prabhu N et al (2014) An exploratory study of the associations between maternal iron status in pregnancy and childhood wheeze and atopy. Br J Nutr 112(12):2018–2027

    Article  CAS  Google Scholar 

  30. Lanzkowsky P (2005) Manual of pediatric hematology and oncology. Elsevier

Download references

Acknowledgements

The authors deeply appreciated the help of our patients to complete this work.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

HA performed the study design, analyzed and interpreted the patient data, and drafted and wrote the manuscript. TD performed the study design and wrote and revised the manuscript. NR did the patient enrollment and collection of the data. YM shared in paper drafting, and AH analyzed the patient data and drafted the manuscript. The authors revised and approved the manuscript.

Corresponding author

Correspondence to Heba A. Ali.

Ethics declarations

Ethics approval and consent to participate

The Research Ethics Committee of the Faculty of Medicine, Ain Shams University, approved the protocol. Written consent was obtained from the patients’ guardians. The reference number is not available at the time being.

Consent for publication

Nothing to declare

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, H.A., Deraz, T.E., Reyad, N.I. et al. Iron status and its relation to lung function in pediatric asthmatics: a cross-sectional study. Egypt J Bronchol 16, 46 (2022). https://doi.org/10.1186/s43168-022-00147-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43168-022-00147-5

Keywords